The activity of the adrenergic system plays an important role in the genesis of malignant arrhythmias and the spreading of the infarcted zone in acute myocardial ischemia. Acute myocardial ischemia induces an increased activity of adenylyl cyclase. This sensitization at the enzyme level as shown in the isolated perfused rat heart occurs rapidly after the onset of ischemia (5-15 minutes) and is rapidly reversible on reperfusion. With prolonged ischemia, it is only transient and is followed by a gradual loss of the adenylyl cyclase activity. The increased activity of adenylyl cyclase is even retained after partial purification, suggesting a covalent modification of the enzyme. Blockade of a,-adrenergic receptors does not prevent this sensitization, demonstrating that it occurs independently of crl-adrenergic receptor activation. Only blockade of protein kinase C by various inhibitors, such as polymyxin B or staurosporine, is able to completely prevent this sensitization process. Moreover, in acute myocardial ischemia an activation of protein kinase C could be identified using its translocation from the cytosol to the particulate fraction as an indicator. Blockade of al-adrenergic receptors using prazosin fails to prevent the activation of protein kinase C and consequently the sensitization of the adenylyl cyclase system, indicating that the ischemia-induced translocation of protein kinase C occurs independently of cvl-adrenergic receptors.
Moreover, in acute myocardial ischemia an activation of protein kinase C could be identified using its translocation from the cytosol to the particulate fraction as an indicator. Blockade of al-adrenergic receptors using prazosin fails to prevent the activation of protein kinase C and consequently the sensitization of the adenylyl cyclase system, indicating that the ischemia-induced translocation of protein kinase C occurs independently of cvl-adrenergic receptors.
These data characterize for the first time an important interaction of two effector enzymes of two distinct signal transduction pathways, i.e., the adenylyl cyclase system and the protein kinase C system in acute myocardial ischemia. Further studies are necessary to identify the mechanisms involved in the activation of protein kinase C in acute ischemia in order to develop therapeutic strategies to prevent such activation of protein kinase C and consequently the sensitization of adenylyl cyclase. (Circulation Research 1992;70:1304-1312) KEY WORDs * acute myocardial ischemia * -adrenergic receptors * adenylyl cyclaseatl-adrenergic receptors * sensitization * protein kinase C C oronary heart disease leading to acute myocardial ischemia may lead to a life-threatening event with the occurrence of malignant arrhythmias or a severe reduction of left ventricular function. Both the spreading of the ischemic zone, resulting in an impairment of contractility, and the genesis of malignant arrhythmias are influenced by the sympathetic system.1"2 Acute myocardial ischemia causes several alterations of the sympathetic system: 1) Local and central mechanisms lead to an increased presynaptic release of endogenous catecholamines. [3] [4] [5] 2) In contrast to expectation, these catecholamines do not induce a desensitization of receptors postsynaptically. Instead, acute myocardial ischemia leads to an increased density of functionally coupled ,3-adrenergic receptors6,7 at the expense of intracellular receptors,7 leading to a receptor-linked sensitization of the adenylyl cyclase system. Ischemia may also lead to an increase of a,-adrenergic receptors. 8 3) Insoluble particles were sedimented (100,00% for 45 minutes at 4°C). The resulting supernatant (solubilized membranes) and the cytosol (see above) were subjected to ion exchange chromatography using DEAE columns (bed volume, 2 ml). After application of the samples to the columns by gravity, the columns were washed with 10 ml of the above buffer, and protein kinase C activity was eluted (2 ml) using the identical buffer with the inclusion of 400 mM NaCl. The eluate was used directly for the determination of protein kinase C activity.
The incubation containing 20 mM Tris-HCl (pH 7. adenylyl cyclase activity was determined in cardiac plasma membranes after 5-50 minutes of global ischemia. As shown in Figure 1 , even very brief periods of ischemia induce an increased enzyme activity with a maximal augmentation of -30% after 10 minutes of global ischemia (306+32 vs. 392±40 pmol cAMP. min1. mg protein-'). This sensitization of forskolinstimulated adenylyl cyclase activity is also observed in the whole homogenate. It is, however, only transient. After 20 minutes of global ischemia, the enzyme activity has returned to control values ( Figure 1) , with a further decrease after 30 and 60 minutes of ischemia (data not shown). Moreover, on reperfusion the early sensitization of the adenylyl cyclase activity is rapidly reversible within 5 minutes (Figure 2 ).
To determine whether other membrane components and specifically G proteins may be responsible for this early ischemia-induced sensitization of adenylyl cyclase, the enzyme was solubilized and partially purified using wheat germ chromatography. As shown in Figure 3 , direct stimulation by forskolin or manganese reveals that the ischemia-induced sensitization of adenylyl cyclase is retained even after solubilization and partial purification of the enzyme. Stimulation by activation of ,B-adrenergic receptors using isoproterenol (data not shown) or stimulation via the stimulatory G protein, GQ, using NaF (Figure 3 ) is lost in this preparation, indicating that the enzyme was effectively separated from receptors and G proteins yet still retained its increased activity after ischemia.
Effect of Prazosin on the Ischemia-Induced Sensitization ofAdenylyl Cyclase
To test whether activation of a,-adrenergic receptors may be involved in this early sensitization process, isolated hearts were perfused with prazosin before the ischemic insult. However, ischemia-induced sensitiza- Figure   4 , all activities of membrane-bound adenylyl cyclase (i.e., basal, isoproterenol-stimulated, and forskolinstimulated activities) were increased after 10 minutes of ischemia even after preperfusion with the al-blocker prazosin. Perfusion with prazosin alone had no effect on adenylyl cyclase activity (data not shown).
Effect of Protein Kinase Inhibitors
The rapid and rapidly reversible sensitization of adenylyl cyclase that was retained after solubilization ification of the enzyme was suggestive of a regulatory modification of the enzyme. To lte whether protein kinase C might be involved rocess, we tested different inhibitors of protein to determine whether they might be able to the ischemia-induced sensitization. rfusion with the specific protein kinase C inhibrmyxin B 23 ( Figure 5 ) or the isoquinolinesulc H-7 24 (data not shown) abolished the inf activity that was observed after 10 minutes of chemia. As shown in Figure 5 , perfusion with in B alone had no effect on forskolin-stimulated cyclase. Additionally, preperfusion with the fotent inhibitor of protein kinase C, stauro-' even at a concentration of 5 x 10`M, was able letely prevent sensitization of adenylyl cyclase )rt periods of global ischemia (Figure 6 ). In experiments, it could be demonstrated that orine at this concentration completely inhibits inase C in vitro (data not shown). data indicate that an activation of protein 'in acute myocardial ischemia may be involved creased adenylyl cyclase activity. In fact, direct n of protein kinase C in the isolated perfused ts using perfusion with phorbol esters such as 12-myristate 13-acetate (PMA) for 5 or 10 was able to induce a sensitization of the adelase comparable to the one observed after chemia ( Figure 7) . Preperfusion with staurowas able to prevent the phorbol-induced senof adenylyl cyclase (data not shown). The ically inactive phorbol ester 4a-phorbol 12,13-ate, which does not stimulate protein kinase C, d to sensitize adenylyl cyclase ( Figure 7 ). Figure 8 , in normoxically perfused hearts (controls), approximately 80-90% of the protein kinase C activity resides in the cytosol, whereas in the particulate fraction, only a small portion of the enzyme activity can be demonstrated (4,408±157 versus 462±+68 pmol/min, Figure 8 ). Indi- translocated from the cytosol to the particulate fraction, indicating its activation. Since stimulation of a,-adrenergic receptors by the presynaptically released catecholamines could be responsible for the activation and translocation of protein kinase C in ischemia, we investigated the effect of the a1-adrenergic receptor antagonist prazosin. In contrast to expectation, blockade of a,-adrenergic receptors was not able to prevent the ischemia-induced translocation of protein kinase C ( Figure 9 ). After preperfusion with prazosin, the significant decrease of protein kinase C activity in the cytosol after 10 minutes of ischemia was unaltered (4,522±172 versus 3,672±125 pmol/min without prazosin, 4,432+137 versus 3,643±213 pmol/min after prazosin).
Similarly, the ischemia-induced increase of protein ki-
+4 -e 0 ao FIGURE 8. Bar graph showing translocation of protein kinase C from the cytosol to the particulate fraction in acute myocardial ischemia. Isolated hearts were preperfused under normoxic conditions. Normoxic perfusion was continued for 10 minutes (control), or ischemia was induced by termination of perfusion for 10 minutes (ischemia). Protein kinase C activity was determined in the cytosolic fraction and in the particulate fraction (see "Materials and Methods" are ineffective in preventing sensitization of adenylyl cyclase. Second, the sensitization of adenylyl cyclase could be documented in the partially purified enzyme preparation, in which other components of the adenylyl cyclase system were removed or functionally uncoupled. These data indicate that the sensitization is independent of other membrane components and that it may be Although this sensitization could be attributed to the enzyme itself, the other components of the adenylyl cyclase system may still potentiate the increased activity and responsiveness when adenylyl cyclase is active within the domain of the plasma membrane of the ischemic heart. These components may include the ischemia-promoted increased release of endogenous catecholamines,5 the increase in functionally coupled fi-adrenergic receptors,7 and the rapid functional loss of the inhibitory G protein (B. Rauch, C. Weinbrenner, F.
Niroomand, R. Marquetant, T. Beyer, C. Schwenke, W.
Kubler, W. Hasselbach, and R.H. Strasser, submitted manuscript), which precedes the late loss of the stimulatory G, protein. 13 The rapid loss of tonic inhibition of adenylyl cyclase promoted by the rapid functional impairment of Gi protein may also explain the slight sensitization of basal adenylyl cyclase when tested in the plasma membranes. This slight increase in basal adenylyl cyclase activity was no longer observed in the partially purified preparation, in which tonic inhibition of adenylyl cyclase by the Gi protein was no longer effective even in the control preparations.
The ischemia-induced sensitization of adenylyl cyclase could be prevented only by pretreatment with different blockers of protein kinase C, such as polymyxine B,23 staurosporine,25 and the isoquinolinesulfonamide H-7.24 Though none of the inhibitors is totally specific, the complete prevention of sensitization by all these different blockers indicates that protein kinase C might be involved in this sensitization process. In isolated model systems, pharmacological activation of protein kinase C predominantly using phorbol esters has been shown previously to modulate the adenylyl cyclase system. [33] [34] [35] In isolated frog erythrocytes, it even has been possible to document phosphorylation and activation of adenylyl cyclase by phorbol ester-activated protein kinase C. 36 Similarly, in the present study, in isolated perfused hearts such sensitization of adenylyl cyclase by phorbol esters mediated by direct activation of protein kinase C was demonstrated and was comparable to the ischemia-induced sensitization of adenylyl cyclase. The molecular mechanism responsible for this sensitization of cardiac adenylyl cyclase in ischemia remains to be evaluated. In isolated systems using purified adenylyl cyclase, phosphorylation of the amino acid serine 481 of the adenylyl cyclase molecule promoted by purified protein kinase C results in a comparable sensitization.3738 These data are also in keeping with the notion that protein kinase C may play a key role in the early, ischemia-induced sensitization of cardiac adenylyl cyclase.
These data led us to investigate whether myocardial ischemia promotes an activation of protein kinase C. As shown here, short periods of ischemia led to a rapid translocation of protein kinase C from the cytosol to the plasma membranes or particulate fraction. Both physiological and pharmacological activation of protein kinase C are known to induce such translocation of the enzyme in isolated cells,2839 brain, and heart.26 These data suggest the rapid activation of protein kinase C in the infarcted heart. To our knowledge, this is the first direct demonstration of a translocation of protein kinase C that was induced by acute myocardial ischemia.
Only in the fetal brain has severe global ischemia been due to a covalent modification of the enzyme itself.
shown to promote a translocation of protein kinase C. 40 The mechanisms by which protein kinase C may be activated in acute myocardial ischemia can only be surmised. Despite the previously observed increase of a1-adrenergic receptors during myocardial ischemia in the cat18 but not in the rat,41 a1-adrenergic activation is not involved. At present, it cannot be excluded that activation of other receptor systems which activate the phosphatidylinositol system, receptor-independent stimulation of phospholipase C,42 or ischemia-induced alterations of intracellular calcium and phospholipid levels43-45 may contribute to the activation of protein kinase C. Further studies are necessary to evaluate such possibilities. A proteolytic activation of protein kinase C by calpain, for example,46 could be excluded since, as shown in the present article, the unstimulated kinase activity in the absence of calcium and phosphatidylserine was unaltered after ischemia. Also, at present, it has not been evaluated which of the different forms of protein kinase C47 present in the heart48 are activated in ischemia.
In the present study, the activation of protein kinase C has been shown to be involved in the sensitization of adenylyl cyclase. Other effects of protein kinase C in acute ischemia, such as direct effects on ion channels,49,50 G proteins,51-53 or the activation of oncogenes54 or the direct negative inotropic effect on contractility of the heart,55 may add to the pathophysiological importance of the activation of protein kinase C in the infarcted heart. Further studies are necessary to evaluate such a potential role of activated protein kinase C in acute myocardial ischemia.
In summary, the present study demonstrates that a newly characterized rapid but a1-receptor-independent activation of protein kinase C may induce the early sensitization of adenylyl cyclase in acute myocardial ischemia. Further studies are necessary to evaluate the molecular mechanisms responsible for this activation and this newly characterized interaction of these two important signal transduction systems, i.e., the adenylyl cyclase system and the phosphatidylinositol system in the acutely infarcted heart. Therapeutic strategies will have to be developed to prevent the deleterious sensitization of adenylyl cyclase and the activation of protein kinase C.
